These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 7792398
1. Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872. Siemann DW. Radiother Oncol; 1995 Jan; 34(1):47-53. PubMed ID: 7792398 [Abstract] [Full Text] [Related]
2. In vitro cytotoxicity and chemosensitizing activity of the dual function nitroimidazole RB 6145. Siemann DW. Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):301-6. PubMed ID: 8195023 [Abstract] [Full Text] [Related]
3. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors. Siemann DW, Sutherland RM. Radiother Oncol; 1992 Aug 15; 24(4):239-45. PubMed ID: 1410579 [Abstract] [Full Text] [Related]
4. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole. Siemann DW, Morrissey S, Wolf K. Cancer Res; 1983 Mar 15; 43(3):1010-3. PubMed ID: 6825075 [Abstract] [Full Text] [Related]
6. Potentiation of CCNU activity by misonidazole in metastases. Siemann DW, Alliet KL. Clin Exp Metastasis; 1987 Mar 15; 5(1):57-63. PubMed ID: 3829497 [Abstract] [Full Text] [Related]
7. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT, Siemann DW. Cancer Res; 1983 Oct 15; 43(10):4709-13. PubMed ID: 6883329 [Abstract] [Full Text] [Related]
9. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069. Siemann DW, Alliet K, Maddison K, Wolf K. Cancer Treat Rep; 1985 Dec 15; 69(12):1409-14. PubMed ID: 3841024 [Abstract] [Full Text] [Related]
10. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice. Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC. Cancer Res; 1985 Jan 15; 45(1):198-202. PubMed ID: 3965132 [Abstract] [Full Text] [Related]
11. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agents. Papadopoulou MV, Mainwaring A, Bloomer WD. Jpn J Cancer Res; 1992 Aug 15; 83(8):907-13. PubMed ID: 1399828 [Abstract] [Full Text] [Related]
12. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. Workman P, Twentyman PR. Br J Cancer; 1982 Aug 15; 46(2):249-59. PubMed ID: 7150475 [Abstract] [Full Text] [Related]
13. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers. Siemann DW. Br J Cancer; 1982 Feb 15; 45(2):272-81. PubMed ID: 6460517 [Abstract] [Full Text] [Related]
14. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069. Siemann DW, Maddison K, Wolf K. Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1657-60. PubMed ID: 6548212 [Abstract] [Full Text] [Related]
15. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas. Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC. Radiat Res; 1990 Oct 15; 124(1 Suppl):S38-43. PubMed ID: 2236508 [Abstract] [Full Text] [Related]
16. Enhanced tumor responses through therapies combining CCNU, MISO and radiation. Siemann DW, Hill SA. Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1623-6. PubMed ID: 6480451 [Abstract] [Full Text] [Related]
17. Potentiation of combination chemotherapy by nitroheterocyclics. Siemann DW, Allalunis-Turner MJ. Int J Radiat Oncol Biol Phys; 1988 Jul 15; 15(1):129-34. PubMed ID: 3391809 [Abstract] [Full Text] [Related]
18. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine. Siemann DW. Cancer Treat Rep; 1983 Mar 15; 67(3):259-65. PubMed ID: 6831472 [Abstract] [Full Text] [Related]
19. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Hirst DG, Brown JM, Hazlehurst JL. Br J Cancer; 1982 Jul 15; 46(1):109-16. PubMed ID: 7201845 [Abstract] [Full Text] [Related]
20. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations. Wong KH, Wallen CA, Wheeler KT. Int J Radiat Oncol Biol Phys; 1990 May 15; 18(5):1043-50. PubMed ID: 2140824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]